Intravenous Transplantation of Human Hair Follicle-Derived Mesenchymal Stem Cells Ameliorates Trabecular Bone Loss in Osteoporotic Mice

    Longshuai Lin, Enjun He, Hongjie Wang, Weihong Guo, Zhenkai Wu, Kai Huang, Qinghua Zhao
    TLDR Human hair follicle stem cells can help treat bone loss in osteoporosis.
    The study demonstrated that intravenous transplantation of human hair follicle-derived mesenchymal stem cells (hHF-MSCs) ameliorated trabecular bone loss in osteoporotic mice by promoting bone formation and inhibiting bone resorption. The research involved 12 mice per group and showed that hHF-MSCs up-regulated OPG and Wnt2b while down-regulating VCAM-1, RANKL, and Noggin, which are key regulators in bone metabolism. This suggested a novel therapeutic potential for hHF-MSCs in treating osteoporosis, offering a promising alternative to other mesenchymal stem cells due to their accessibility and potential for long-term storage and use. However, further studies were needed to understand the detailed mechanisms and long-term effects of this treatment.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results